VeriChip Corporation Appoints Jonathan Musher, MD, CMD Chief Medical Officer and Vice President, Medical Affairs
April 12 2007 - 9:30AM
PR Newswire (US)
Former president of the American Medical Directors Association
encourages use of VeriChip RFID implantable microchip for high-risk
patients DELRAY BEACH, Fla., April 12 /PRNewswire/ -- VeriChip
announced today that it has appointed Jonathan Musher, MD, CMD
Chief Medical Officer and Vice President, Medical Affairs. Dr.
Musher served as President of the American Medical Directors
Association (AMDA) from 1998 to 1999. As Chief Medical Officer and
Vice President, Medical Affairs, Dr. Musher will oversee VeriChip's
medical activities related to the continued implementation of the
VeriMed Patient Identification System, including clinical research
and medical information. Dr. Musher has over 20 years of clinical
hands-on medical experience. His expertise spans the spectrum of
acute care and long-term care services, from inpatient and
ambulatory care through home and hospice care to skilled nursing
care. He has published and lectured extensively in the areas of
Geriatrics, Long Term Care, and Medical Direction. Scott Silverman,
Chairman and Chief Executive Officer of VeriChip, stated, "As the
world's premier RFID company for people, we are very proud to have
Dr. Musher, a highly regarded physician, on our team. He is a
strong advocate of the VeriMed Patient Identification System and
its potential to help long-term care patients, a target population
for the VeriMed system. His relationships within the medical
community are a substantial advantage for VeriChip." "Following its
approval by the Food and Drug Administration in October 2004, I
have been a champion of the VeriChip and feel it is vital for high-
risk patients," said Dr. Musher. "I believe this revolutionary
product not only provides for a higher overall standard of care,
but also can save lives in an emergency situation. In my new role
at VeriChip I will continue to strive for widespread adoption among
target populations." Dr. Musher is Chair of the AMDA Foundation, a
member of the AMDA Public Policy Committee, and was a recent
delegate to the White House Conference on Aging. He is also a
member of several Medical Boards and Committees including the
National Assisted Living Task Force. About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida,
develops, markets and sells radio frequency identification, or
RFID, systems used to identify, locate and protect people and
assets. VeriChip's goal is to become the leading provider of RFID
systems for people in the healthcare industry. VeriChip sells
passive RFID systems for identification purposes and active RFID
systems for local-area location and identification purposes.
VeriChip recently began to market its VeriMed(TM) Patient
Identification System for rapidly and accurately identifying people
who arrive in an emergency room and are unable to communicate. This
system uses the first human-implantable passive RFID microchip, the
implantable VeriChip(TM), cleared for medical use in October 2004
by the United States Food and Drug Administration. VeriChip
Corporation is majority-owned by Applied Digital Inc.
(NASDAQ:ADSXNASDAQ:-NASDAQ:News), which also owns a majority
position in Digital Angel Corporation (AMEX:DOCAMEX:-AMEX:News).
For more information on VeriChip, please call 1-800-970-2447, or
email . Additional information can be found online at
http://www.verichipcorp.com/. Statements about the Company's future
expectations, including future revenues and earnings, and all other
statements in this press release other than historical facts are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Litigation
Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties and are subject to change at any time, and the
Company's actual results could differ materially from expected
results. The Company undertakes no obligation to update
forward-looking statements to reflect subsequently occurring events
or circumstances. Contact: VeriChip Corporation Allison Tomek
561-805-8000 The Ruth Group Nick Laudico (investors) (646) 536-7030
Jason Rando (media) (646) 536-7025 DATASOURCE: VeriChip Corporation
CONTACT: Allison Tomek, VeriChip Corporation, +1-561-805-8000, or ;
or for Investors, Nick Laudico, The Ruth Group, +1-646-536-7030, or
, or for Media, Jason Rando, +1-646-536-7025, or Web site:
http://www.verichipcorp.com/
Copyright
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From Apr 2024 to May 2024
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From May 2023 to May 2024